News

Article

Sponsored Content

Best Practices, Strategies & Use of Novel Biological Responses for Robust Cell-Based Potency Assays

Author(s):

Cell-based assays (CBAs) are key tools for evaluating the potency of new biologic drugs. Catalent’s transcription-based bioassay simplifies and empowers the testing of new biologics.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.